Loading data for FMS — first visit, this takes a few seconds.

알림

Fresenius Medical Care AG (FMS)

NYSE: FMS · 실시간 가격 · USD

23.50

-0.27 (-1.14%)

종가 기준: Aug 18, 2026, 8:00 PM

23.50

-0.25%

프리마켓: 6:10 AM

-1.14% (1D)

데이터 없음

매수호가	23.7
시가총액	12.54B
매출 (ttm)	19.43B
순이익 (ttm)	937.78M
베타	0.84
EPS (ttm)	1.92
P/E (ttm)	12.27
선행 P/E	6.49
P/B (ttm)	0.86
P/S (ttm)	0.65
Earnings Date	Nov 3, 2026

매도호가	n/a
거래량	492,004
평균 거래량 (20일)	734,881
시가	23.77
전일 종가	23.77
일중 범위	23.50 - 23.86
52주 범위	20.02 - 27.64
애널리스트	n/a
목표주가	n/a
배당	$0.87 (3.71%)
배당락일	2026년 5월 22일

FMS 소개

Fresenius Medical Care AG provides dialysis and related services for individuals with renal diseases in Germany, the United States, and internationally. The company offers dialysis treatment and related laboratory and diagnostic services through a network of outpatient dialysis clinics; materials, training, and patient support services comprising clinical monitoring, follow-up assistance, and arranging for delivery of the supplies to the patient'...

[더 보기]

산업 Medical Care Facilities

섹터 Healthcare

IPO 일자 Sep 17, 1996

직원 수 107,226

상장 거래소 NYSE

티커 FMS

웹사이트 https://www.freseniusmedicalcare.com

전체 기업 정보

재무 실적

2025년 Fresenius Medical Care의 매출은 19.63B로, 전년 19.34B 대비 1.51% 증가했습니다. 순이익은 978.37M로, 81.88% 증가했습니다.

재무제표

어닝 서프라이즈

Fresenius Medical Care가 Aug 3, 2026에 분기 실적을 발표했습니다:

매출 n/a 예상치 하회 $0, 및 -100.00% 전년 대비 감소.

EPS 0.56 예상치 상회 0.06, 및 21.74% 전년 대비 성장.

다음 실적 발표

Fresenius Medical Care AG의 실적 발표 예정일은 Nov 3, 2026, 정규장 중입니다.
애널리스트 예상 매출은 ... 업그레이드

뉴스

1주 전 · Motley Fool

Fresenius Medical Care (FMS) Q2 2026 Earnings Call Transcript

U.S. referral execution gap offset by strong margin expansion and transformation savings.

1주 전 · Zacks

FMS Q2 Earnings Rise on Care Delivery, Revenues Miss, Margins Expand

FMS posts 28% EPS growth as Care Delivery profitability and margin gains offset a quarterly revenue miss and weaker US treatment volumes.

1주 전 · Simply Wall St.

Fresenius Medical Care (XTRA:FME) Expands BEACON US To Build Its Case For HVHDF

Fresenius Medical Care is expanding its BEACON-US clinical initiative to build real-world evidence for high-volume hemodiafiltration therapy in the U.S. The program evaluates the 5008X CAREsystem and ...

2주 전 · Simply Wall St.

Fresenius Medical Care (XTRA:FME) Stock Looks Like A Bargain Despite Weak Returns

Fresenius Medical Care stock has recovered modestly in the short term yet is still down about 30% over the past five years, while recent valuation checks suggest the market may be pricing it on the ch...

2주 전 · Simply Wall St.

Is Fresenius Medical Care (XTRA:FME) Undervalued Following Its New CEO Appointment?

Fresenius Medical Care (XTRA:FME) has drawn fresh attention after the Supervisory Board appointed Cassie McLean as Management Board member and Chief Executive Officer of the Care Delivery segment, res...

2 페이지 중 1

Fresenius Medical Care AG (FMS)